Stocksigma LogoStocksigma Logo

Bliss GVS Pharma Schedules Board Meeting for Q2 FY27 Financial Results

Bliss GVS Pharma Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated

Bliss GVS Pharma Schedules Board Meeting for Q2 FY27 Financial Results

Bliss GVS Pharma Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Bliss GVS Pharma Schedules Board Meeting for Q2 FY27 Financial Results Bliss GVS Pharma Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed for designated persons and their immediate relatives from 1st Oct'26 and will remain shut until 48 hours post-declaration of the financial results.

Original exchange filing (PDF)

More announcements from Bliss GVS Pharma Ltd

All Bliss GVS Pharma Ltd announcements